Quick Dispatch:
Your retatrutide trial data First Retatrutide phase 3 data, a Triumph of Science! orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your retatrutide trial data First Retatrutide phase 3 data, a Triumph of Science! ships.
Need Help?
Questions about retatrutide trial data First Retatrutide phase 3 data, a Triumph of Science!, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for retatrutide trial data First Retatrutide phase 3 data, a Triumph of Science! in your area.
Early trial data for retatrutide demonstrates exceptional weight loss results, reaching approximately 21% placebo-adjusted weight loss by week 48. This performance significantly exceeds all other leading obesity medications currently under
28.29
Today we shared new results on retatrutide, an investigational, first-of-its-kind treatment we're studying in adults with obesity or overweight with at least one weight-related comorbidity. Read more about the Phase 3 findings:
24.84
Retatrutide, an Amazing Future for Weight Loss
27.48
Retatrutide Weight Loss Results Trial Data and FDA Status
26.16
Retatrutide just delivered the first top-line Phase 3 results for a triple agonist in obesity — and the findings from TRIUMPH-4 are striking👇
25.01
Retatrutide just delivered the most powerful weight loss data ever recorded in a Phase 3 obesity trial. At 104 weeks, participants on the 12 mg dose lost an average of 85 pounds
20.15
NEW Data drop at #ADA2023: Retatrutide, a triple agonist (GLP1, GIP, glucagon) lost an incredible 24.2% of their body weight, which amounts to 58 lbs! This data suggests retatrutide is the most
22.60
:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)
